Pharis Mohideen
Net Worth

Last updated:

What is Pharis Mohideen net worth?

The estimated net worth of Dr. Pharis Mohideen is at least $2,330,473 as of 25 Nov 2024. He owns shares worth $1,071,100 as insider, has earned $8,853 from insider trading and has received compensation worth at least $1,250,520 in null.

What is the salary of Pharis Mohideen?

Dr. Pharis Mohideen salary is $625,260 per year as Chief Medical Officer in null.

How old is Pharis Mohideen?

Dr. Pharis Mohideen is 60 years old, born in 1965.

What stocks does Pharis Mohideen currently own?

As insider, Dr. Pharis Mohideen owns shares in one company:

Company Title Shares Price per share Total value
(DBVT) Chief Medical Officer 111,110 $9.64 $1,071,100

What does do?

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.

DBVT logo
DBVT
$9.64

Pharis Mohideen insider trading

Dr. Pharis Mohideen has made 7 insider trades between 2023-2024, according to the Form 4 filled with the SEC. Most recently he sold 565 units of DBVT stock worth $322 on 25 Nov 2024.

The largest trade he's ever made was exercising 2,350 units of DBVT stock on 21 Nov 2024. As of 25 Nov 2024 he still owns at least 111,110 units of DBVT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Ordinary Shares 565 $0.57 $322
Sale
Ordinary Shares 342 $0.53 $181
Sale
Ordinary Shares 2,350 $0.54 $1,269
Sale
Ordinary Shares 1,785 $0.98 $1,749
Sale
Ordinary Shares 660 $1.36 $898
Sale
Ordinary Shares 382 $1.38 $527
Sale
Ordinary Shares 2,245 $1.74 $3,906

key executives

executives and other stock owners filed with the SEC:

  • Dr. Pharis Mohideen (60) Chief Medical Officer
  • Mr. Daniel Tassé (65) Chief Executive Officer & Director
  • Mr. Sébastien Robitaille (55) Chief Financial Officer